Synthesis, <i>in silico</i> study and cytotoxic evaluation of new benzimidazole derivatives as potential aromatase inhibitors


Isik A., Daoud N. E., Ciftci K. U., Çongur G., Ay E. N., Bagci E. R., ...More

FUTURE MEDICINAL CHEMISTRY, 2026 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Publication Date: 2026
  • Doi Number: 10.1080/17568919.2026.2748643
  • Journal Name: FUTURE MEDICINAL CHEMISTRY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Chemical Abstracts Core, EMBASE, MEDLINE, Natural Science Collection (ProQuest), Biological Science Database (ProQuest), Health Research Premium Collection (ProQuest)
  • Anadolu University Affiliated: Yes

Abstract

Aims A new series of benzimidazole derivatives (4a-4p) was designed, synthesized, and evaluated as potential aromatase inhibitors with anticancer activity.Materials and methods The anticancer effects of the compounds were evaluated using the MCF-7 cell line. Derivatives that showed activity were subjected to an aromatase inhibition assay. Molecular docking, molecular dynamics simulations, and in silico ADMET profiling were performed for the selected compounds.Results Among the series, para-substituted derivatives 4d (Cl), 4h (OC2H5), and 4k (F) exhibited potent antiproliferative activity with low-micromolar IC50 values (2.40-2.64 & micro;M), surpassing cisplatin, while maintaining favorable selectivity profiles.Conclusions This experimental and computational study identifies 4d as a promising lead for further development as a non-steroidal aromatase inhibitor for breast cancer therapy.